Current approaches to alternative therapy in menopausal syndrome (a review)
Abstract
Vasomotor symptoms are most common signs of the menopausal syndrome. Frequent episodes of flushes and hyperhidrosis affect sleep, mood, and quality of life. Menopausal hormone therapy (MHT) remains the «gold standard» of treatment. However, some women have contraindications to MHT, and others refuse to take hormones due to personal reasons. In such cases, alternative therapy may become an option. This article presents a review of the literature regarding the role of alternative therapy in the treatment of vasomotor symptoms. We searched Russian and international data bases for pharmacological products (natural and synthetic) used to relieve menopausal flushes. The review presents medication registered in the Russian Federation as well as products used abroad.
About the Authors
A. G. Mamontova
Regional Clinical Hospital № 3
Russian Federation
Russian Federation
Mamontova Alexandra Georgievna – Obstetrician-gynecologist, Department of Obstetrics and Pathology of Pregnancy № 1
287, prospekt Pobedy, Chelyabinsk, 454021
Е. N. Usoltseva
South Ural State Medical University, Health Ministry of Russian Federation
Russian Federation
Russian Federation
Usoltseva Elena Nikolaevna – PhD, Assistant, Department of Obstetrics and Gynecology, Institute of Continuing Professional Education
64, ul. Vorovskogo, Chelyabinsk, 454092
References
1. Kim M.Y., Choi S.D., Ryu A. Is complementary and alternative therapy effective for women in the climacteric period? J Menopausal Med. 2015; 21 (1): 28-35. DOI: 10.6118/jmm.2015.21.1.28.
2. Menopausal hormone therapy and maintaining the health of mature women. Clinical recommendations (Treatment protocol). [Menopauzal'naya gormonoterapiya i sohranenie zdorov'ya zhenshchin zrelogo vozrasta. Klinicheskie rekomendacii (Protokol lecheniya)]. Pis'mo Ministerstva zdravoohraneniya Rossijskoj Federacii ot 02.10.2015 № 15-4/10/2-5804 (in Russian). URL: https://studfiles.net/preview/5778779/ [Accessed: 18.03.2018].
3. Eden J. Endocrine dilemma: Managing menopausal symptoms after breast cancer. Eur J Endocrinol. 2016; 174 (3): 71-7. DOI: 10.1530/EJE-15-0814. DOI: 10.1530/ EJE-15-0814. PMID: 26466611.
4. Fisher W.I., Johnson A.K., Elkins G.R. et al. Risk factors, pathophysiology, and treatment of hot flashes in cancer. CA Cancer J Clin. 2013; 63 (3): 167-92. DOI: 10.3322/caac.2117.
5. Wiśniewska I., Jochymek B., Lenart-Lipińska M., Chabowski M. The pharmacological and hormonal therapy of hot flushes in breast cancer survivors. Breast Cancer. 2016; 23: 178-82. DOI: 10.1007/s12282-015-0655-2.
6. Drewe J., Bucher K.A., Zahner C. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. SpringerPlus. 2015; 4: 65. DOI: 10.1186/s40064-015-0808-y.eCollection 2015.
7. Lapochkina N.P., Matasheva A.V., Krupenina E.A. Selective serotonin reuptake inhibitors in menopausal syndrome. [Selektivnye ingibitory obratnogo zahvata serotonina pri klimaktericheskom syndrome]. Vestnik Ivanovskoj medicinskoj akademii. 2015; 20 (4): 34-8 (in Russian).
8. Vorontsova A.V., Zvychayny M.A. The tissue selective modulator of estrogen activity is an adequate «alternative» hormone therapy. [Tkaneselektivnyj modulyator ehstrogenovoj aktivnosti adekvatnost' «al'ternativnoj» gormonal'noj terapii]. Ural'skij medicinskij zhurnal. 2013; 4 (109): 16-21 (in Russian).
9. Goldberg T., Fidler B. Conjugated estrogens/ bazedoxifene (Duavee): a novel agent for the treatment of moderate-to-severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis. P T. 2015; 30 (3): 178-82. PMCID: PMC4357350.
10. Pup L.D. Ospemifene: a safe treatment of vaginal atrophy. Eur Rev Med Pharmacol Sci Year. 2016; 20 (18): 3934-44.
11. An K.C. Selective estrogen receptor modulators. Asian Spine J. 2016; 10 (4): 787-91. DOI: 10.4184/asj.2016.10.4.787.
12. Pazhekattu R., Lau A.N., Adachi J.D. The tissue-selective estrogen complex: a review of current evidence. Rheumatol Ther. 2015; 2 (1): 47-58. DOI: 10.1007/s40744-015-0013-z.
13. Gursoy A.Y., Kiseli M., Caglar G.S. Melatonin in aging women. Climacteric. 2015; 18: 1-7. DOI: 10.3109/13697137.2015.1052393.
14. Parandavar N., Abdali K., Keshtgar S. et al. The effect of melatonin on climacteric symptoms in menopausal women; a double-blind, randomized controlled, clinical trial. Iran J Public Health. 2014; 43 (10): 1405-16.
15. Kotlarczyk M.P., Lassila H.C., O'Neil C.K. et al. Melatonin osteoporosis prevention study (MOPS): a randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women. J Pineal Res. 2012; 52 (4): 414-26. DOI: 10.1111/j.1600-079X.2011.00956.x.
16. Chen W.Y., Giobbie-Hurder A., Gantman K. et al. A randomized, placebo-controlled trial of melatonin on breast cancer survivors: impact on sleep, mood, and hot flashes. Breast Cancer Res Treat. 2014; 145 (2): 381-8. DOI: 10.1007/s10549-014-2944-4.
17. Maltseva L.I., Gafarova E.A., Garipova G.Kh. The role of melatonin in regulation of gonads function and the possibility of its application in the treatment of symptoms of the pathological menopause. [Rol' melatonina v regulyacii funkcii polovyh zhelez i vozmozhnosti ego primeneniya v lechenii simptomov patologicheskogo klimaksa]. Uspekhi gerontologii. 2007; 20 (4): 68-74 (in Russian).
18. Kuznetsova I.V. Burchakov D.I. Possibilities for the treatment of climacteric symptoms with melatonin preparations. [Vozmozhnosti terapii klimaktericheskih simptomov s pomoshch'yu preparatov melatonina]. Ginekologiya. 2015; 17 (5): 44-8 (in Russian).
19. Usoltseva E.N., Bryukhina E.V. The use of melatonin in the treatment of climacteric syndrome. [Primenenie melatonina v lechenii klimaktericheskogo sindroma]. II Mezhdunarodnaya nauchno-prakticheskaya konferenciya Evrazijskogo Nauchnogo Ob"edineniya «Sovremennye koncepcii nauchnyh issledovanij»: sbornik nauchnyh rabot. Moskva. 2015: 94 (in Russian).
20. Bryukhina E.V., Usoltseva E.N. Melatonin is the key to the adaptation of the female body to climacteric syndrome. [Melatonin – klyuch k adaptacii zhenskogo organizma pri klimaktericheskom syndrome]. Vrach. 2016; 4: 68-71 (in Russian).
21. Prilepskaya V.N., Bogatova I.K., Radzinsky V.E. New in the prevention and therapy of climacteric syndrome. [Novoe v profilaktike i terapii klimaktericheskogo sindroma]. Ginekologiya. 2016; 148 (1): 7-12 (in Russian).
22. Ovsyannikova T.V., Makarov I.O., Kulikov I.A. Clinical efficacy of non-hormonal methods of therapy in women in perimenopause. [Klinicheskaya effektivnost' negormonal'nyh metodov terapii u zhenshchin v perimenopauze]. Akusherstvo, ginekologiya i reprodukciya. 2013; 7 (3): 26-9 (in Russian).
23. Pandya K.J., Morrow G.R., Roscoe J.A. et al. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial. Lancet. 2005; 366 (9488): 818-24.
24. Freedman R.R. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol. 2014; 142: 115-20. DOI: 10.1016/j.jsbmb.2013.08.010.
25. Kuznetsova I.V. Phytoestrogens in the treatment of climacteric disorders. [Fitoehstrogeny v lechenii klimaktericheskih rasstrojstv]. Ginekologiya. 2012; 14 (6): 20-23 (in Russian). ISSN: 2079-5696.
26. Manual on menopause: a guide for doctors. [Rukovodstvo po klimakteriyu: rukovodstvo dlya vrachej (Pod red. V.P. Smetnik, V.I. Kulakova)]. Moskva: MIA. 2001: 685 s (in Russian). ISBN 5-89481-076-0.
27. Geller S.E., Studee L. Contemporary alternatives to plant estrogens for menopause. Maturitas. 2006; 55 (Suppl 1): 3-13.
28. Cheng G., Wilczek B., Warner M. et al. Isoflavone treatment for acute menopausal symptoms. Menopause. 2007; 14 (3 Pt 1): 468-73.
29. D'Anna R., Cannata M.L., Atteritano M. et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study. Menopause. 2007; 14 (4): 648-55.
30. Tikhomirov A.L. Soy isoflavones in the treatment of climacteric syndrome. [Izoflavony soi v lechenii klimaktericheskogo sindroma]. Ginekologiya. 2008; 10 (2): 44-6 (in Russian).
31. Wuttke W., Seidlova-Wuttke D., Batzer I. Phytoestrogens: dangerous drugs or soft hormones? In: Menopause. The State of Art – in research and management. The Parthenon Publishing Group [Ed. H.P.G. Schntider]. Boca Raton, London, New York, Washington. 2003: 295-306.
32. Wuttke W., Jarry H., Seidlova-Wuttke D. Isoflavones – safe food additives or dangerous drugs? Ageing Res Rev. 2007; 6 (2): 150-88.
33. Radzinsky V.E., Khamoshina M.B., Shestakova I.G., Osmakova A.A. Menopausal syndrome – therapy and prevention: the proven possibilities of phytoestrogens. [Menopauzal'nyj sindrom – terapiya i profilaktika: dokazannye vozmozhnosti fitoehstrogenov]. Doktor.Ru. 2015; 14 (115): 32-7 (in Russian).
34. Lethaby A., Marjoribanks J., Kronenberg F. et al. Phytoestrogens for menopausal vasomotor symptoms. Cochrane Database Syst Rev. 2013; 10 (12): CD001395. DOI: 10.1002/14651858.CD001395.pub4.
35. Bryukhina E.V., Usoltseva E.N., Ivanova O.V. Life quality of women in menopause: the problem, the solutions: monograph. [Kachestvo zhizni zhenshchin v menopauze: problema, puti resheniya: monografiya]. Chelyabinsk: Izd-vo YuUGMU. 2013: 99 s (in Russian). ISBN 978-5-94507-184-1.
36. Li L., Lv Y., Xu L., Zheng Q. Quantitative efficacy of soy isoflavones on menopausal hot flashes. Br J Clin Pharmacol. 2015; 79 (4): 593-604. DOI: 10.1111/bcp.12533.
37. Ho S.C., Chan A.S., Ho Y.P. et al. Effects of soy isoflavone supplementation on cognitive function in Chinese postmenopausal women: a double-blind, randomized, controlled trial. Menopause. 2007; 14 (3): 489-99.
38. Kuznetsova I.V., Voichenko N.A., Akarachkova E.A. Phytoestrogens in the treatment and prevention of menopausal disorders. [Fitoehstrogeny v lechenii i profilaktike menopauzal'nyh rasstrojst. Medicinskij sovet. 2010; 3-4: 42-3 (in Russian).
39. Udani J.K., Brown D.J., Tan M.O., Hardy M. Pharmacokinetics and bioavailability of plant lignan 7-hydroxymatairesinol and effects on serum enterolactone and clinical symptoms in postmenopausal women: a single-blinded, parallel, dose-comparison study. J Am Coll Nutr. 2013; 32 (6): 428-35. DOI: 10.1080/07315724.2013.849578.
40. Pruthi S., Qin R., Terstreip S.A. et al. A phase III, randomized, placebo-controlled, doubleblind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause. 2012; 19 (1): 48-53. DOI: 10.1097/gme.0b013e318223b021.
41. Ghazanfarpour M., Sadegh R., Latifnejad R. at al. Effects of Flaxseed and Hypericum perforatum on hot flash, vaginal atrophy and estrogen-dependent cancers in menopausal women: a systematic review and metaanalysis. Avicenna J Phytomed. 2016; 6 (3): 273-83.
42. Ghazanfarpour M., Sadeghi R., Abdolahian S., Latifnejad Roudsari S.A. The efficacy of Iranian herbal medicines in alleviating hot flashes: A systematic review. Int J Reprod Biomed (Yazd, Iran). 2016; 14 (3): 155-66.
43. Menopause. Biology and pathobiology. Eds. R.A. Lobo, J. Kelsey, R. Marcus. Academic Рress. 2000: 657 p.
44. Shahnazi M., Nahaee J., Mohammad-AlizadehCharandabi S., Bayatipayan S. Effect of black cohosh (cimicifuga racemosa) on vasomotor symptoms in postmenopausal women: a randomized clinical trial. J Caring Sci. 2013; 2 (2): 105-13. DOI: 10.5681/jcs.2013.013.
45. Hajirahimkhan A., Dietz D.M., Bolton J.L. Botanical modulation of menopausal symptoms: Mechanisms of action? Planta Med. 2013; 79 (7): 538-53. DOI: 10.1055/s-0032-1328187.
46. Vikhlyaeva E.M. Postmenopausal therapy. Effect on menopausal related symptoms, the course of chronic diseases and quality of life. [Postmenopauzal'naya terapiya. Vliyanie na svyazannye s menopauzoj simptomy, techenie hronicheskih zabolevanij i kachestvo zhizni]. Moskva: MEDpress-inform. 2008: 448 s (in Russian). ISBN 5-98322-387-9.
47. Rafaelian I.V., Balan V.E., Kovaleva L.A. Efficacy and safety of the application of richemose cymicifuge extract in the treatment of climacteric syndrome during the year (results of own research. [Effektivnost' i bezopasnost' primeneniya ekstrakta cimicifugi racemozy v terapii klimaktericheskogo sindroma v techenie goda (rezul'taty sobstvennogo issledovaniya)]. Medicinskij sovet. 2014; 7: 54-7 (in Russian).
48. Apaydin E.A., Maher A.R., Shanman R. et al. A systematic review of St. John’s wort for major depressive disorder. Syst Rev. 2016; 5 (1): 148. DOI: 10.1186/s13643-016-0325-2.
49. Lee H.W., Choi J., Lee Y. et al. Ginseng for managing menopausal woman's health A systematic review of double-blind, randomized, placebo-controlled trials. Medicine (Baltimore). 2016; 95 (38): e4914. DOI: 10.1097/md.0000000000004914.
50. Mirabi P., Mojab F. The effects of valerian root on hot flashes in menopausal women. Iran J Pharm Res. 2013; 12 (1): 217-22.
51. Zilber V.S. Place of homeopathy in the system of Russian public health. Part I. [Mesto gomeopatii v sisteme Rossijskogo zdravoohraneniya. Chast' I]. Klinicheskaya medicina. 2014; 92 (3): 74-8 (in Russian).
For citation:
Mamontova A.G., Usoltseva Е.N. Current approaches to alternative therapy in menopausal syndrome (a review). Obstetrics, Gynecology and Reproduction. 2018;12(2):39-47. (In Russ.) https://doi.org/10.17749/2313-7347.2017.12.2.039-047
Views: 370
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
